Aprogen Biologics (003060.KS) Earnings Analysis
Aprogen Biologics (003060.KS) has no confirmed upcoming earnings date. Trailing P/E -0.21.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 003060.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 003060.KS. This page updates as the calendar is published.
003060.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -2,735.53 KRW | n/a | n/a | n/a |
| 2025-05-14 | -3,268.36582 KRW | n/a | n/a | n/a |
| 2025-03-13 | -4,553.37331 KRW | n/a | n/a | n/a |
| 2024-08-14 | -2,234.78261 KRW | n/a | n/a | n/a |
003060.KS valuation and analyst view
| Trailing P/E | -0.21 |
|---|---|
| Trailing EPS | -9,961.04715 KRW |
| Price / book | 0.14 |
| Dividend yield | 0.00% |
| Market cap | 26.09B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Aprogen Biologics (003060.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 003060.KS. This page updates as the calendar is published.
Did 003060.KS beat earnings last quarter?
Consensus estimate data was not available for 003060.KS's 2026-03-12 report.
What is 003060.KS's current P/E ratio and EPS?
003060.KS trades at a trailing P/E of -0.21 on trailing EPS of -9961.047145460067 KRW.
What do analysts rate 003060.KS?
003060.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.